DARE BIOSCIENCE ($DARE) posted quarterly earnings results for Q3 2026 on Monday, November 16th. The company reported earnings of -$0.18 per share, beating estimates of -$0.27 by $0.09. The company also reported revenue of $50,000, missing estimates of $2,058,696 by $-2,008,696.
Stock price change since market close: -6.22%
You can see Quiver Quantitative's $DARE stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
DARE BIOSCIENCE Hedge Fund Activity
We have seen 21 institutional investors add shares of DARE BIOSCIENCE stock to their portfolio, and 12 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 232,787 shares (+3418.3%) to their portfolio in Q3 2026, for an estimated $198,637
- US BANCORP \DE\ added 100,000 shares (+82.7%) to their portfolio in Q3 2026, for an estimated $85,330
- XTX TOPCO LTD added 37,376 shares (+inf%) to their portfolio in Q3 2026, for an estimated $31,892
- JANE STREET GROUP, LLC removed 36,092 shares (-100.0%) from their portfolio in Q3 2026, for an estimated $30,797
- TWO SIGMA SECURITIES, LLC added 19,656 shares (+inf%) to their portfolio in Q3 2026, for an estimated $16,772
- NORTHERN TRUST CORP added 18,778 shares (+121.7%) to their portfolio in Q2 2026, for an estimated $39,621
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 17,130 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $36,144
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
DARE BIOSCIENCE Analyst Ratings
Wall Street analysts have issued reports on $DARE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Ladenburg Thalmann issued a "Buy" rating on 10/26/2026
To track analyst ratings and price targets for DARE BIOSCIENCE, check out Quiver Quantitative's $DARE forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.